Evidence for a major quantitative trait locus on chromosome 17q21 affecting low-density lipoprotein peak particle diameter

Circulation

Volumn 107, Issue 18, 2003, Pages 2361-2368

  Bossé, Yohan ^a,b   Pérusse, Louis ^b   Després, Jean Pierre ^a,b,c   Lamarche, Benoît ^a,d   Chagnon, Yvon C ^d   Rice, Treva ^e   Rao, D C ^e   Bouchard, Claude ^f   Vohl, Marie Claude ^a,b,d  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Genes; Genetics; Genome; Lipoproteins

Indexed keywords

APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; GENE PRODUCT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; BODY MASS; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 5Q; FEMALE; GEL ELECTROPHORESIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; QUANTITATIVE TRAIT LOCUS;

ADULT; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE; QUANTITATIVE TRAIT LOCI;

EID: 0037986588     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000065577.60129.F5     Document Type: Article

References (53)

1. Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 1999;25:199-211.
2. Austin MA, Newman B, Selby JV, et al. Genetics of LDL subclass phenotypes in women twins: concordance, heritability, and commingling analysis. Arterioscler Thromb. 1993;13:687-695.
3. Lamon-Fava S, Jimenez D, Christian JC, et al. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis. 1991;91:97-106.
4. Austin MA, Jarvik GP, Hokanson JE, et al. Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol. 1993;10:599-604.
5. de Graaf J, Swinkels DW, de Haan AF, et al. Both inherited susceptibility and environmental exposure determine the low-density lipoproteinsubfraction pattern distribution in healthy Dutch families. Am J Hum Genet. 1992;51:1295-1310.
6. Austin MA, King MC, Vranizan KM, et al. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
7. Austin MA, Brunzell JD, Fitch WL, et al. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520-530.
8. Bredie SJ, Kiemeney LA, de Haan AF, et al. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet. 1996;58:812-822.
9. Friedlander Y, Kark JD, Sinnreich R, et al. Inheritance of LDL peak particle diameter: results from a segregation analysis in Israeli families. Genet Epidemiol. 1999;16:382-396.
10. Zambon A, Deeb SS, Hokanson JE, et al. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998;18:1723-1729.
11. Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res. 1998;39:228-232.
12. Allayee H, Dominguez KM, Aouizerat BE, et al. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J Lipid Res. 2000;41:245-252.
13. Couture P, Otvos JD, Cupples LA, et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2000;20:815-822.
14. Haffner SM, Stern MP, Miettinen H, et al. Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler Thromb Vasc Biol. 1996;16:1184-1188.
15. Schaefer EJ, Lamon-Fava S, Johnson S, et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb. 1994;14:1105-1113.
16. Okumura K, Matsui H, Kawakami K, et al. Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects. Clin Chim Acta. 1999;285:91-103.
17. Barbagallo CM, Polizzi F, Severino M, et al. ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Eur J Epidemiol. 2001;17:707-713.
18. Dart AM, Cooper B. Independent effects of apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states. Arterioscler Thromb Vasc Biol. 1999;19:2465-2473.
19. Zhao SP, Verhoeven MH, Vink J, et al. Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis. 1993;102:147-154.
20. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000;20:1323-1329.
21. Couture P, Otvos JD, Cupples LA, et al. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis. 2000;148:337-343.
22. Couture P, Otvos JD, Cupples LA, et al. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res. 1999;40:1883-1889.
23. Vohl MC, Tchernof A, Dionne FT, et al. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men. Diabetes. 1996;45:1405-1411.
24. Russo GT, Meigs JB, Cupples LA, et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 2001;158:173-181.
25. LaBelle M, Austin MA, Rubin E, et al. Linkage analysis of low-density lipoprotein subclass phenotypes and the apolipoprotein B gene. Genet Epidemiol. 1991;8:269-275.
26. Austin MA, Wijsman E, Guo SW, et al. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia. Genet Epidemiol. 1991;8:287-297.
27. Nishina PM, Johnson JP, Naggert JK, et al. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA. 1992;89:708-712.
28. Rotter JI, Bu X, Cantor RM, et al. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet. 1996;58:585-594.
29. Naggert JK, Recinos A, Lamerdin JE, et al. The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene. Clin Genet. 1997;51:236-240.
30. Hokanson JE, Brunzell JD, Jarvik GP, et al. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet. 1999;64:608-618.
31. Talmud PJ, Edwards KL, Turner CM, et al. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter. Circulation. 2000;101:2461-2466.
32. Allayee H, Aouizerat BE, Cantor RM, et al. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am J Hum Genet. 1998;63:577-585.
33. Austin MA, Talmud PJ, Luong LA, et al. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet. 1998;62:406-419.
34. Austin MA, Stephens K, Walden CE, et al. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype. Atherosclerosis. 1999;142:79-87.
35. Rainwater DL, Almasy L, Blangero J, et al. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol. 1999;19:777-783.
36. Bouchard C. Genetic epidemiology, association, and sib-pair linkage: results from the Quebec Family Study. In: Bray GA, Ryan DH, eds. Molecular and Genetic Aspects of Obesity. Baton Rouge, La: Louisiana State University Press; 1996:470-481.
37. St-Pierre AC, Ruel IL, Cantin B, et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation. 2001;104:2295-2299.
38. Chagnon YC, Borecki IB, Perusse L, et al. Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism. 2000;49:203-207.
39. Marshfield Clinic Research Foundation. Center for Medical Genetics. Available at: http://research.marshfieldclinic.org/genetics/. Accessed April 7, 2003.
40. The Genetic Epidemiology Research Group, Human Genetics Division, University of Southampton School of Medicine. Location Database map. Available at: http://cedar.genetics.soton.ac.uk/public_html. Accessed April 7, 2003.
41. The Genome Database: An International Collaboration in Support of the Human Genome Project (hosted by The Hospital for Sick Children, Toronto, Ontario, Canada). Available at: http://gdbwww.gdb.org/. Accessed April 7, 2003.
42. OMIM: Online Mendelian Inheritance in Man. Available at: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmap. Accessed April 7, 2003.
43. S. A. G. E. Statistical Analysis for Genetic Epidemiology, release 4.0. Computer program package available from the Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, Metro Health Campus, Case Western Reserve University, Cleveland, Ohio, 1999.
44. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet. 2000;66:279-292.
45. Perusse L, Rice T, Chagnon YC, et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes. 2001;50:614-621.
46. Rao DC, Province MA. The future of path analysis, segregation analysis, and combined models for genetic dissection of complex traits. Hum Hered. 2000;50:34-42.
47. Nakaya Y, Schaefer EJ, Brewer HB, Jr. Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun. 1980;95:1168-1172.
48. Mehdi H, Aston CE, Sanghera DK, et al. Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet. 1999;105:63-71.
49. Sepehrnia B, Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoproteins, VIII: role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. Hum Genet. 1989;82:118-122.
50. Cassader M, Ruiu G, Gambino R, et al. Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis. 1994;110:45-51.
51. Keidar S, Kaplan M, Shapira C, et al. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis. 1994;107:71-84.
52. Keidar S, Kaplan M, Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Thromb Vasc Biol. 1996;16:97-105.
53. Hurt-Camejo E, Camejo G, Sartipy P. Phospholipase A2 and small, dense low-density lipoprotein. Curr Opin Lipidol. 2000;11:465-471.